For the Quarter Ending March 2026
Levetiracetam Prices in North America
- In the USA, the Levetiracetam Price Index rose by 6.01% quarter-over-quarter, reflecting tighter imports and higher freight.
- The average Levetiracetam price for the quarter was approximately USD 28552.33/MT, reflecting modest supply tightness.
- March registered a Levetiracetam Spot Price rise as freight and prioritised orders tightened US allocations.
- Levetiracetam Production Cost Trend showed higher landed costs as Trans-Pacific freight and feedstock inflation rose.
- Levetiracetam Demand Outlook remains steady with approximately three million patients and prescription growth sustaining baseline consumption.
- Inventories were overall adequate, so the Levetiracetam Price Index stayed firm amid balanced distributor holdings.
- Analysts expect the Levetiracetam Price Forecast to reflect freight swings and exporter prioritisation of demand.
- Competitor bidding and payer formularies limited pass-through, tempering spot offers, and moderating Levetiracetam Spot Price volatility.
Why did the price of Levetiracetam change in March 2026 in North America?
- Trans-Pacific freight rose significantly, raising landed costs and directly increasing CFR Los Angeles import prices.
- Indian and Chinese exporters prioritised higher-margin regional orders, reducing volumes available for United States buyers.
- Domestic formulary changes expanded Tier-6 coverage, boosting prescriptions and supporting suppliers in passing increased costs.
Levetiracetam Prices in APAC
- In China, the Levetiracetam Price Index rose by 6.01% quarter-over-quarter, driven by tightened export availability and buying.
- The average Levetiracetam price for the quarter was approximately USD 28447.33/MT across FOB Shanghai shipments.
- Levetiracetam Spot Price strengthened as inventories fell below two weeks, prompting sellers to lift offers.
- Levetiracetam Price Forecast indicates softening after March surge as export enquiries moderate and inventories rebuild.
- Levetiracetam Production Cost Trend rose due to firmer pyrrolidone and -butyrolactone prices, narrowing conversion margins.
- Levetiracetam Demand Outlook remains export-driven with continued US and European tender reallocation supporting near-term volumes.
- Levetiracetam Price Index volatility increased as environmental inspections tightened supply while exporters prioritized contract shipments.
- Logistics risk from Strait of Hormuz disruptions raised freight premiums, influencing seller offers and contract lead times.
Why did the price of Levetiracetam change in March 2026 in APAC?
- Late-February and March environmental enforcement actions forced mid-scale plants to pause, materially reducing exportable supply.
- Firmer pyrrolidone and -butyrolactone feedstock prices increased conversion costs, allowing producers to lift FOB offers.
- Accelerated overseas purchases, prompted by regulatory actions against Indian suppliers, significantly boosted Chinese export demand.
Levetiracetam Prices in Europe
- In Germany, the Levetiracetam Price Index rose by 6.08% quarter-over-quarter, driven by tighter cargo allocations.
- The average Levetiracetam price for the quarter was approximately USD 28557.33/MT, reflecting mixed monthly movements.
- Levetiracetam Spot Price firmed amid constrained allocations, with higher freight and elevated landed costs pressuring offers.
- Levetiracetam Price Forecast indicates short-term firmness as buyers secure forward volumes ahead of spring tenders.
- Levetiracetam Production Cost Trend showed pressure from higher ocean freight and insurance surcharges, nudging FOB quotations.
- Levetiracetam Demand Outlook remains steady with ageing population-driven prescriptions and hospital restocking supporting baseline consumption.
- Levetiracetam Price Index reflected parallel-trade outflows tightening local inventories, limiting downside despite modest demand growth.
- Major exporters maintained campaigns but diverted volumes to higher-margin markets, tightening European CFR availability and allotments.
Why did the price of Levetiracetam change in March 2026 in Europe?
- Tighter cargo availability from India and Spain reduced spot allocations, increasing competition for inbound cargoes.
- Higher ocean freight surcharges and conflict-linked insurance costs raised landed costs, pushing parity offers upward.
- Restocking by wholesalers and hospital buying ahead of tenders increased immediate demand, tightening short-term availability.
For the Quarter Ending December 2025
APAC
- In China, the Levetiracetam Price Index fell by 0.77% quarter-over-quarter, reflecting softer export inquiries globally.
- The average Levetiracetam price for the quarter was approximately USD 26833.33/MT reflecting FOB Shanghai quarterly billing levels.
- Levetiracetam Spot Price showed limited spot activity as exporters trimmed offers to allocate cargoes before holidays.
- Levetiracetam Price Forecast indicates modest volatility with cautious seller offers and measured international restocking demand.
- Levetiracetam Production Cost Trend remained benign with stable feedstock supply and no significant coal tariff pressure.
- Levetiracetam Demand Outlook was stronger for export markets while domestic procurement shifted to measured replenishment.
- Levetiracetam Price Index reflected marginal quarterly weakness amid ample inventories and steady plant operating rates.
- Market logistics and currency movements supported Chinese FOB competitiveness, constraining upward pricing pressure despite firm margins.
Why did the price of Levetiracetam change in December 2025 in APAC?
- Export inquiries thinned after buyers completed tender cycles, reducing spot purchase urgency and lowering offers.
- Stable feedstock availability, uninterrupted plant output kept conversion costs subdued, limiting cost pressure on FOB.
- Year-end inventory positions and pragmatic distributor purchasing reduced demand, prompting sellers to trim prices slightly.
Europe
- In Germany, the Levetiracetam Price Index fell by 0.69% quarter-over-quarter, reflecting normalized imports and eased freight.
- The average Levetiracetam price for the quarter was approximately USD 350175.00/MT, per assessed CFR Hamburg transactions.
- Levetiracetam Spot Price remained subdued amid ample Indian and Spanish cargoes, enabling buyers to negotiate lower landed terms.
- Levetiracetam Price Forecast signals modest recovery into early 2026 driven by restocking and steady pharmaceutical procurement.
- Levetiracetam Production Cost Trend showed limited upward pressure due to contained acetonitrile and stable Asian natural gas inputs.
- Levetiracetam Demand Outlook remains stable driven by ageing demographics and hospital restocking ahead of tender cycles.
- Levetiracetam Price Index softness reflected rising distributor inventories and disciplined exporter offers from India and Spain.
- Hamburg port efficiency and steady EUR-USD parity reduced landed cost volatility, constraining abrupt Levetiracetam Price Index movements.
Why did the price of Levetiracetam change in December 2025 in Europe?
- Ample exports from India and Spain kept supply abundant, preventing year-end buying and pressuring CFR quotations lower.
- Stable EUR-USD exchange and contained freight costs limited landed-cost inflation, reducing upward pressure on German buyers.
- No reported plant outages and balanced inventories led distributors to avoid aggressive restocking, sustaining mildly bearish sentiment.
North America
- In USA, Levetiracetam Price Index fell by 0.68% quarter-over-quarter, reflecting eased freight and normalized exports.
- The average Levetiracetam price for the quarter was approximately USD 350185.00/MT, and reflecting balanced inventories.
- Levetiracetam Spot Price softened as competitive generic bids and ample Asian inventories pressured CFR offers.
- Levetiracetam Price Forecast suggests mild volatility with modest restocking, importer discipline, and cautious phased procurement.
- Levetiracetam Production Cost Trend showed limited upward pressure as freight declines offset persistent feedstock inflation.
- Levetiracetam Demand Outlook remains stable, supported by steady prescriptions, formulary positioning, and predictable downstream offtake.
- Levetiracetam Price Index movements were modest, influenced by port efficiencies, tariff truce, and regulatory environment.
- Balanced imports, comfortable coastal inventories, and selective restocking are expected to govern CFR pricing dynamics.
Why did the price of Levetiracetam change in December 2025 in North America?
- Reduced China-to-USA freight rates trimmed landed costs in December, enabling importers to lower CFR quotations.
- Intense year-end generic bidding compressed margins, prompting sellers to concede modest discounts for calendar contracts.
- Comfortable distributor inventories and predictable prescription demand reduced urgency, limiting spot buying and upward pressure.
For the Quarter Ending September 2025
North America
- In the USA, the Levetiracetam Price Index rose by 2.45% quarter-over-quarter, driven by higher import costs and steady downstream demand.
- The average Levetiracetam price for the quarter was approximately USD 30263.33/MT, reflecting elevated import and freight costs.
- Levetiracetam Spot Price showed intramonth volatility as Chinese offers and freight variations altered landed procurement economics.
- Levetiracetam Price Forecast indicates modest upward bias due to restocking, firm pharmaceutical demand, and constrained export availability.
- Levetiracetam Production Cost Trend reflects higher Asian export offers and freight, supporting seller pricing power despite stable manufacturing.
- Levetiracetam Demand Outlook remains constructive from API producers and formulators, underpinning firm offtake into the quarter.
- Elevated inventories intermittently pressured the Levetiracetam Price Index, but strategic restocking maintained transactional momentum among distributors.
- Export demand and operational status of major suppliers influenced offers, with small supply disruptions tightening selective regional availability.
Why did the price of Levetiracetam change in September 2025 in North America?
- Higher import costs and freight increases raised landed costs, pressuring domestic procurement margins and offers.
- Tightening export offers from Asian suppliers reduced availability, prompting urgent restocking and stronger seller pricing.
- Elevated domestic inventories and cautious buyer behaviour limited spot buying, moderating momentum despite cost pressures.
APAC
- In China, the Levetiracetam Price Index rose by 2.83% quarter-over-quarter, driven by tight inventories recently.
- The average Levetiracetam price for the quarter was approximately USD 30233.33/MT on FOB Shanghai basis.
- Levetiracetam Spot Price strengthened amid flood-induced plant closures and accelerated restocking by overseas buyers recently.
- Levetiracetam Price Forecast points to modest gains as sustained export enquiries offset intermittent production restarts.
- Levetiracetam Production Cost Trend shows upward pressure from higher logistics and raw material expenses affecting margins.
- Levetiracetam Demand Outlook remains constructive with steady pharmaceutical offtake and renewed international procurement interest emerging.
- Levetiracetam Price Index volatility reflected seasonal shutdowns, inventory swings, currency effects and targeted supplier discounting.
- Major plant disruptions and subsequent restarts constrained availability, influencing exports, inventories and transactional Levetiracetam pricing dynamics.
Why did the price of Levetiracetam change in September 2025 in APAC?
- Resumption of production in August increased supply while July flood damage previously tightened availability materially.
- Elevated inventories and subdued overseas procurement in August reduced buying urgency, pressuring spot pricing downward.
- Currency movements and logistics costs altered export margins, prompting exporters to adjust offers and profitability.
Europe
- In Germany, the Levetiracetam Price Index rose by 2.64% quarter-over-quarter, driven by higher import costs.
- The average Levetiracetam price for the quarter was approximately USD 30270.67/MT, according to CFR Hamburg data.
- Levetiracetam Spot Price softened as Asian exporters eased offers and domestic inventories remained elevated recently.
- Levetiracetam Price Forecast indicates mild recovery ahead, supported by restocking and steady pharmaceutical procurement activity.
- Levetiracetam Production Cost Trend showed upward pressure from freight increases and higher Asian producer offers.
- Levetiracetam Demand Outlook remains positive due to stronger German pharmaceutical manufacturing and new order volumes.
- Levetiracetam Price Index volatility eased as freight stabilized, but buyers remained cautious on bulk replenishment.
- Inventory levels remained high, export demand softened, while major suppliers reported steady rates and availability.
Why did the price of Levetiracetam change in September 2025 in Europe?
- Reduced import costs and eased Asian offers lowered landed procurement expenses, pressuring domestic quotations further.
- Elevated German inventories and cautious buyer behaviour limited fresh orders, weakening demand and transactional volumes.
- Earlier high freight charges increased landed costs, though subsequent freight stabilization eased import cost pressures.
For the Quarter Ending June 2025
North America
- Levetiracetam Price Index in North America witnessed an upward shift in July 2025 as Levetiracetam (Bulk) spot prices rose from June levels, reflecting elevated import-related expenses and stronger demand sentiment across the U.S. pharmaceutical market.
- Levetiracetam Spot Price for Levetiracetam (Bulk) CFR Los Angeles was USD 29888 in June 2025, and prices trended higher in July as sellers responded to ongoing cost inflation from origin countries.
- Levetiracetam Price Forecast for Q3 2025 suggests a moderately bullish outlook supported by firm downstream demand, persistent high freight rates from Asia, and a weaker U.S. Dollar that is expected to keep import costs elevated.
- Levetiracetam Production Cost Trend continued to tighten as Chinese exporters raised FOB values in response to lower inventories and export quotas, which combined with currency depreciation, inflated the landed cost for U.S. buyers.
- Levetiracetam Demand Outlook remained strong, driven by consistent procurement from formulators producing antiepileptic and neurological drugs, while upbeat manufacturing data and stable prescription activity reinforced buyer confidence.
Why did the price change in July 2025?
- Prices increased in July 2025 due to rising export quotations from China, elevated container freight rates to U.S. ports, and stable-to-firm downstream pharmaceutical demand that allowed importers to pass on higher costs..
Europe
- Price Index in Europe (Germany) showed a mild upward movement in July 2025, continuing the positive trend from May and June, as Levetiracetam (Bulk) prices rose slightly due to persistent import cost inflation and firm pharmaceutical demand across the region.
- Levetiracetam Spot Price in June 2025 was USD 29810 for Levetiracetam (Bulk) CFR Los Angeles, and in July, prices in Europe climbed further in response to elevated freight rates from Asia and tightening stock levels at domestic warehouses.
- Price Forecast for Q3 2025 remains cautiously bullish, as steady growth in Germany’s pharmaceutical manufacturing sector and restocking demand from formulation units are expected to uphold strong import interest and price stability.
- Levetiracetam Production Cost Trend continues to show moderate pressure, with Chinese suppliers maintaining higher FOB offers amidst thinning inventories and stronger Asian and European demand. Euro strength against the US Dollar offered only partial relief to buyers.
- Levetiracetam Demand Outlook remains positive, underpinned by increased order volumes from German pharmaceutical plants producing antiepileptic and neurological drugs. Renewed healthcare investment and growing outpatient drug usage also supported rising demand.
Why did the price change in July 2025?
- Prices increased in July 2025 across Germany due to a combination of firm demand from pharmaceutical buyers, higher freight charges from Asia, tight inventory levels, and elevated export prices from Asia. The continued recovery in Germany’s manufacturing sector and strong purchasing sentiment contributed to the upward pricing pressure.
APAC
- Levetiracetam Price Index in APAC (China) showed consistent upward movement from April to July 2025, with July continuing the bullish trend due to tightening inventories, reduced output, and sustained international demand.
- Levetiracetam Spot Price in June 2025 for Levetiracetam (Bulk) CFR Los Angeles was USD 29,700, reflecting stable export volumes despite constrained production and ongoing currency headwinds from a weakening US Dollar.
- Levetiracetam Price Forecast for Q3 2025 remains firm, supported by anticipated export growth, limited inventory replenishment, and continued strong demand from overseas pharmaceutical importers—particularly in Southeast Asia and the US.
- Levetiracetam Production Cost Trend in July remained elevated, due to currency pressure (USD depreciation), rising raw material expenses, and higher energy costs during peak summer operations in China, prompting suppliers to adjust pricing upward to protect margins.
- Levetiracetam Demand Outlook in July was optimistic, as downstream demand remained strong across pharmaceutical formulation sectors in both the domestic market and major export destinations. Active restocking and new order inflows continued to support healthy procurement volumes.
Why did the price change in July 2025?
- Prices increased in July 2025 due to lower domestic inventories, high raw material and processing costs, and robust export demand. Chinese suppliers faced additional margin pressure from the depreciating US Dollar, prompting upward pricing adjustments. Improved overseas demand—especially from the US and Europe—kept offtake levels strong, further tightening supply and supporting higher prices.
